Latest Insider Transactions at Odonate Therapeutics, Inc. (ODTC)
This section provides a real-time view of insider transactions for Odonate Therapeutics, Inc. (ODTC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Odonate Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Odonate Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2021
|
Eco R1 Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,545,000
-95.09%
|
$5,545,000
$1.61 P/Share
|
|
Dec 09
2021
|
Eco R1 Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
156,669
-2.75%
|
$156,669
$1.82 P/Share
|
|
Dec 01
2021
|
Eco R1 Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
185,941
-3.16%
|
$185,941
$1.66 P/Share
|
|
Dec 01
2021
|
Eco R1 Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
185,941
+3.16%
|
$185,941
$1.66 P/Share
|
|
Nov 24
2021
|
Boxer Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
200,000
-4.54%
|
$200,000
$1.57 P/Share
|
|
Nov 22
2021
|
Boxer Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
200,000
-4.34%
|
$200,000
$1.55 P/Share
|
|
Nov 19
2021
|
Aaron I. Davis Director |
SELL
Open market or private sale
|
Indirect |
150,000
-3.15%
|
$150,000
$1.84 P/Share
|
|
Nov 19
2021
|
Aaron I. Davis Director |
SELL
Open market or private sale
|
Direct |
30,000
-6.31%
|
$30,000
$1.92 P/Share
|
|
Nov 19
2021
|
Tang Kevin C Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
365,289
-2.78%
|
$365,289
$1.92 P/Share
|
|
Nov 19
2021
|
Boxer Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
150,000
-3.15%
|
$150,000
$1.84 P/Share
|
|
Nov 18
2021
|
Aaron I. Davis Director |
SELL
Open market or private sale
|
Indirect |
250,000
-4.99%
|
$250,000
$1.95 P/Share
|
|
Nov 18
2021
|
Tang Kevin C Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
1,094,265
-2.63%
|
$1,094,265
$1.91 P/Share
|
|
Nov 18
2021
|
Boxer Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
250,000
-4.99%
|
$250,000
$1.95 P/Share
|
|
Nov 17
2021
|
Aaron I. Davis Director |
SELL
Open market or private sale
|
Indirect |
600,000
-10.7%
|
$1,200,000
$2.17 P/Share
|
|
Nov 17
2021
|
Aaron I. Davis Director |
SELL
Open market or private sale
|
Direct |
170,000
-26.33%
|
$340,000
$2.23 P/Share
|
|
Nov 17
2021
|
Tang Kevin C Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
1,287,577
-2.14%
|
$2,575,154
$2.22 P/Share
|
|
Nov 17
2021
|
Boxer Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
600,000
-10.7%
|
$1,200,000
$2.17 P/Share
|
|
Mar 15
2021
|
Joseph P O'Connell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
99
+2.67%
|
$1,584
$16.22 P/Share
|
|
Mar 15
2021
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37
+1.39%
|
$592
$16.22 P/Share
|
|
Feb 26
2021
|
Joseph P O'Connell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
90
+2.5%
|
$1,530
$17.89 P/Share
|
|
Feb 26
2021
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34
+1.3%
|
$578
$17.89 P/Share
|
|
Feb 12
2021
|
Joseph P O'Connell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
76
+2.17%
|
$1,596
$21.19 P/Share
|
|
Feb 12
2021
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28
+1.09%
|
$588
$21.19 P/Share
|
|
Jan 29
2021
|
Joseph P O'Connell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
82
+2.39%
|
$1,558
$19.64 P/Share
|
|
Jan 29
2021
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31
+1.21%
|
$589
$19.64 P/Share
|
|
Jan 15
2021
|
Joseph P O'Connell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
94
+2.8%
|
$1,504
$16.99 P/Share
|
|
Jan 15
2021
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35
+1.39%
|
$560
$16.99 P/Share
|
|
Dec 31
2020
|
Joseph P O'Connell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
169
+5.06%
|
$2,704
$16.32 P/Share
|
|
Dec 31
2020
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
350
+12.48%
|
$5,600
$16.32 P/Share
|
|
Dec 30
2020
|
Aaron I. Davis Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+1.75%
|
$1,700,000
$17.46 P/Share
|
|
Dec 30
2020
|
Boxer Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100,000
+1.75%
|
$1,700,000
$17.46 P/Share
|
|
Dec 29
2020
|
Craig A Johnson Director |
BUY
Open market or private purchase
|
Direct |
3,000
+50.0%
|
$51,000
$17.0 P/Share
|
|
Dec 29
2020
|
Aaron I. Davis Director |
BUY
Open market or private purchase
|
Indirect |
225,000
+3.93%
|
$3,825,000
$17.11 P/Share
|
|
Dec 28
2020
|
Aaron I. Davis Director |
BUY
Open market or private purchase
|
Indirect |
75,000
+1.4%
|
$1,200,000
$16.9 P/Share
|
|
Dec 28
2020
|
Boxer Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
300,000
+2.66%
|
$5,100,000
$17.01 P/Share
|
|
Dec 23
2020
|
Tang Kevin C Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
139,138
+0.45%
|
$2,087,070
$15.57 P/Share
|
|
Dec 22
2020
|
Tang Kevin C Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
74,502
+0.24%
|
$1,043,028
$14.88 P/Share
|
|
Dec 21
2020
|
Tang Kevin C Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
62,144
+0.4%
|
$870,016
$14.58 P/Share
|
|
Dec 15
2020
|
Joseph P O'Connell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
121
+3.88%
|
$1,452
$12.91 P/Share
|
|
Dec 15
2020
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43
+2.0%
|
$516
$12.91 P/Share
|
|
Nov 30
2020
|
John G Lemkey Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.35%
|
$144
$12.77 P/Share
|
|
Nov 30
2020
|
Joseph P O'Connell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
122
+4.07%
|
$1,464
$12.77 P/Share
|
|
Nov 30
2020
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45
+2.14%
|
$540
$12.77 P/Share
|
|
Nov 13
2020
|
John G Lemkey Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
96
+2.71%
|
$1,152
$12.2 P/Share
|
|
Nov 13
2020
|
Joseph P O'Connell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
128
+4.44%
|
$1,536
$12.2 P/Share
|
|
Nov 13
2020
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46
+2.23%
|
$552
$12.2 P/Share
|
|
Oct 30
2020
|
John G Lemkey Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
96
+2.79%
|
$1,152
$12.25 P/Share
|
|
Oct 30
2020
|
Joseph P O'Connell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
127
+4.61%
|
$1,524
$12.25 P/Share
|
|
Oct 30
2020
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46
+2.28%
|
$552
$12.25 P/Share
|
|
Oct 15
2020
|
John G Lemkey Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
88
+2.63%
|
$1,144
$13.35 P/Share
|